Clin2
NCT07628127Likely a fitRecruiting

Weight loss pill study for adults with excess weight

ObesityOverweight

Part of Hormones & metabolism clinical trials.

This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
332 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are an adult (male or female) of any gender identity.
  • You are overweight or have obesity, with a body mass index (BMI) between 25 and 40, depending on the study group.
  • Your weight is stable (no more than 5% change in the last 3 months) and you weigh at least 70 kg (about 154 lbs).
  • You do not have diabetes (your blood sugar tests are in the normal range).
  • You have not used certain weight-loss or diabetes medications (like GLP-1 drugs) in the past 6 months.
  • You are generally healthy, aside from conditions like mild high blood pressure or cholesterol issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido
NCT07743463Recruiting· Phase 3
Daily pill for weight loss in adults with excess weight or weight-related health issues

This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.

Birmingham, Alabama
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07291232Recruiting· Phase 1
Study of an injected drug for adults with obesity

This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.

Anaheim, California
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.